HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

alpha-eudesmol, a P/Q-type Ca(2+) channel blocker, inhibits neurogenic vasodilation and extravasation following electrical stimulation of trigeminal ganglion.

Abstract
In this study, we investigated the effect of alpha-eudesmol, which potently inhibits the presynaptic omega-agatoxin IVA-sensitive (P/Q-type) Ca(2+) channel, on neurogenic inflammation following electrical stimulation of rat trigeminal ganglion. Treatment with alpha-eudesmol (0.1-1 mg/kg. i.v.) dose-dependently attenuated neurogenic vasodilation in facial skin monitored by a laser Doppler flowmetry. In addition, alpha-eudesmol (1 mg/kg. i.v.) significantly decreased dural plasma extravasation in analysis using Evans blue as a plasma marker. On the other hand, alpha-eudesmol (1 mg/kg, i.v.) did not affect mean arterial blood pressure in rats. The calcitonin gene-related peptide (CGRP) and substance P (SP) released from activated sensory nerves have recently been suggested to be associated with the neurogenic inflammation. In this study, we also showed that alpha-eudesmol (0.45-45 microM) concentration-dependently inhibits the depolarization-evoked CGRP and SP release from sensory nerve terminals in spinal cord slices. These results indicate that the anti-neurogenic inflammation action of alpha-eudesmol, which does not affect the cardiovascular system, may be due to its presynaptic inhibition of the neuropeptide release from perivascular trigeminal terminals. We also suggest that the omega-agatoxin IVA-sensitive Ca(2+) channel blocker, alpha-eudesmol, may become useful for the treatment of the neurogenic inflammation in the trigemino-vascular system such as migraine.
AuthorsK Asakura, T Kanemasa, K Minagawa, K Kagawa, T Yagami, M Nakajima, M Ninomiya
JournalBrain research (Brain Res) Vol. 873 Issue 1 Pg. 94-101 (Aug 04 2000) ISSN: 0006-8993 [Print] Netherlands
PMID10915814 (Publication Type: Journal Article)
Chemical References
  • Calcium Channel Blockers
  • Calcium Channels, P-Type
  • Calcium Channels, Q-Type
  • Sesquiterpenes, Eudesmane
  • Terpenes
  • Substance P
  • Evans Blue
  • alpha-eudesmol
  • Calcitonin Gene-Related Peptide
Topics
  • Animals
  • Blood Pressure (drug effects)
  • Calcitonin Gene-Related Peptide (metabolism)
  • Calcium Channel Blockers (pharmacology)
  • Calcium Channels, P-Type (drug effects)
  • Calcium Channels, Q-Type (drug effects)
  • Electric Stimulation
  • Evans Blue (pharmacokinetics)
  • Extravasation of Diagnostic and Therapeutic Materials (metabolism)
  • Face
  • Nerve Endings (metabolism)
  • Neurons, Afferent (metabolism)
  • Rats
  • Rats, Wistar
  • Sesquiterpenes, Eudesmane
  • Skin (blood supply)
  • Spinal Cord (cytology, metabolism)
  • Substance P (metabolism)
  • Terpenes (pharmacology)
  • Trigeminal Ganglion (physiology)
  • Vasodilation (drug effects, physiology)

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: